Impregnil (letrozole) 2.5mg tabs
Composition:
- Each tablet contains 2.5mg of Letrozole as the active ingredient.
Indications for Impregnil (Letrozole 2.5mg):
- Impregnil is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women.
- It is also sometimes used off-label for fertility treatment in women with ovulation problems.
Dosage of Impregnil (Letrozole 2.5mg):
- The usual recommended dose of Impregnil (Letrozole 2.5mg) for breast cancer treatment is one tablet (2.5mg) taken orally once a day.
- For fertility treatment, the dosage and duration may vary based on individual circumstances and should be determined by a healthcare provider.